Skill Checkup: An Elderly Man With Leg Pain and Weakness

Maria-Victoria Mateos, MD, PhD; Simon J. Harrison, MBBS, PhD


April 04, 2022

Three of these choices—history of stroke, high-risk cytogenetics, and history of tibial fracture—are all relevant components of the patient’s presentation. However, the history of MM with high-risk cytogenetics is likely the most important aspect. Although the first-line regimen induced remission, MM is almost never "cured," particularly without transplant. The presence of high-risk cytogenetics (del17p positivity) strongly suggests the likelihood of relapse.

A history of stroke is a red flag for further cerebrovascular events and should be investigated if it has not been previously. Long-term anticoagulation is a risk given the gait problems, but given the increased incidence of venous thromboembolism with many MM therapies, there may be added benefit from continuing this. Finally, although some late-occurring complication with the patient's previous tibial fracture may be contributing to ongoing gait issues, new-onset pain in both legs and weakness are less likely to be related.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.